The US FDA is instituting a new IT system that tracks the source of drugs to help control the risks of drugs manufactured in foreign countries. For countries like China, the new system asks companies to increase their cooperation with the US pharmaceutical regulator. Drug companies whose products are well documented will be rewarded with expedited customs clearance. More details....